2018 台湾共识建议:接受同步放化疗的头颈部肿瘤患者的营养干预

2018-06-01 台湾多学科工作组(统称) Oral Oncol. 2018 Jun;81:16-21.

由于其解剖学位置,头颈部肿瘤患者经常在确诊时已经存在吞咽困难和营养不良,并且这些情况通常会在放疗后加剧。因此临床急需该类患者的营养干预共识,本文由来自台湾的多学科专家小组共同制定,主要内容涉及营养不良的影响,预防性管饲的作用以及接受放化疗患者口服营养补充剂的益处等。

中文标题:

2018 台湾共识建议:接受同步放化疗的头颈部肿瘤患者的营养干预

英文标题:

Consensus and clinical recommendations for nutritional intervention for head and neck cancer patients undergoing chemoradiotherapy in Taiwan

发布日期:

2018-06-01

简要介绍:

由于其解剖学位置,头颈部肿瘤患者经常在确诊时已经存在吞咽困难和营养不良,并且这些情况通常会在放疗后加剧。因此临床急需该类患者的营养干预共识,本文由来自台湾的多学科专家小组共同制定,主要内容涉及营养不良的影响,预防性管饲的作用以及接受放化疗患者口服营养补充剂的益处等。 

拓展指南:头颈部相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2018 台湾共识建议:接受同步放化疗的头颈部肿瘤患者的营养干预)] GetToolGuiderByIdResponse(projectId=1, id=3a05e1c0016029ec, title=2018 台湾共识建议:接受同步放化疗的头颈部肿瘤患者的营养干预, enTitle=Consensus and clinical recommendations for nutritional intervention for head and neck cancer patients undergoing chemoradiotherapy in Taiwan, guiderFrom=Oral Oncol. 2018 Jun;81:16-21., authorId=null, author=, summary=由于其解剖学位置,头颈部肿瘤患者经常在确诊时已经存在吞咽困难和营养不良,并且这些情况通常会在放疗后加剧。因此临床急需该类患者的营养干预共识,本文由来自台湾的多学科专家小组共同制定,主要内容涉及营养不良的影响,预防性管饲的作用以及接受放化疗患者口服营养补充剂的益处等。 , cover=, journalId=null, articlesId=null, associationId=1588, associationName=台湾多学科工作组(统称), associationIntro=, copyright=0, guiderPublishedTime=Fri Jun 01 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<div>由于其解剖学位置,头颈部肿瘤患者经常在确诊时已经存在吞咽困难和营养不良,并且这些情况通常会在放疗后加剧。因此临床急需该类患者的营养干预共识,本文由来自台湾的多学科专家小组共同制定,主要内容涉及营养不良的影响,预防性管饲的作用以及接受放化疗患者口服营养补充剂的益处等。 </div> <div><br> </div>拓展指南:<strong>与<font color=red>头颈部</font>相关指南:</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=49abd1c001585195" title="3D打印非共面坐标模板辅助CT引导放射性125I粒子植入治疗头颈部肿瘤专家共识" target=_blank>3D打印非共面坐标模板辅助CT引导放射性125I粒子植入治疗头颈部肿瘤专家共识</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=78c5b1c001559a3c" title="NCCN临床实践指南:头颈部肿瘤(2018.V1)" target=_blank>NCCN临床实践指南:头颈部肿瘤(2018.V1)</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=d60b81c0015a00ba" title="头颈部肿瘤放疗者营养与支持治疗专家共识" target=_blank>头颈部肿瘤放疗者营养与支持治疗专家共识</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=1b0471c00153a4ca" title="2017 CAP指南:头颈部恶性肿瘤患者人类乳头瘤病毒检测" target=_blank>2017 CAP指南:头颈部恶性肿瘤患者人类乳头瘤病毒检测</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=3802d1c001a3229b" title="NCCN临床实践指南:头颈部肿瘤(2017.V2)" target=_blank>NCCN临床实践指南:头颈部肿瘤(2017.V2)</a></li> 更多信息请点击:<a href="http://www.medsci.cn/guideline/list.do?q=%E5%A4%B4%E9%A2%88%E9%83%A8" target=_blank>有关头颈部更多指南</a></ul>, tagList=[TagDto(tagId=4764, tagName=同步放化疗), TagDto(tagId=661, tagName=头颈部肿瘤), TagDto(tagId=63657, tagName=营养干预)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=30, categoryName=耳鼻咽喉科, tenant=100), CategoryDto(categoryId=66, categoryName=营养科, tenant=100), CategoryDto(categoryId=73, categoryName=头颈外科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=6116, appHits=148, showAppHits=0, pcHits=4636, showPcHits=1867, likes=142, shares=5, comments=2, approvalStatus=1, publishedTime=Wed Jun 13 21:59:26 CST 2018, publishedTimeString=2018-06-01, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Wed Jun 13 21:59:26 CST 2018, updatedBy=null, updatedName=null, updatedTime=Fri Jan 05 11:54:13 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2018 台湾共识建议:接受同步放化疗的头颈部肿瘤患者的营养干预)])
2018 台湾共识建议:接受同步放化疗的头颈部肿瘤患者的营养干预
下载请点击:
评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=324105, encodeId=13a4324105bd, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2ac82155377, createdName=1201e5c5m39暂无昵称, createdTime=Thu Jun 14 11:42:27 CST 2018, time=2018-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=323945, encodeId=6c7a3239451c, content=^_^^_^^_^, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Swp2ehfHpiciczeTntUyQOlIGMzQ705ic67sdMTVMbwTv7KbmlUvxrGvRSvQZjPkz7ib5tEDfIaORgczPtmHDpwojg/0, createdBy=c54b2163125, createdName=wqkm, createdTime=Wed Jun 13 22:46:38 CST 2018, time=2018-06-13, status=1, ipAttribution=)]
    2018-06-14 1201e5c5m39暂无昵称

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=324105, encodeId=13a4324105bd, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2ac82155377, createdName=1201e5c5m39暂无昵称, createdTime=Thu Jun 14 11:42:27 CST 2018, time=2018-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=323945, encodeId=6c7a3239451c, content=^_^^_^^_^, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Swp2ehfHpiciczeTntUyQOlIGMzQ705ic67sdMTVMbwTv7KbmlUvxrGvRSvQZjPkz7ib5tEDfIaORgczPtmHDpwojg/0, createdBy=c54b2163125, createdName=wqkm, createdTime=Wed Jun 13 22:46:38 CST 2018, time=2018-06-13, status=1, ipAttribution=)]
    2018-06-13 wqkm

    ^_^^_^^_^

    0